These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3035177)

  • 1. Nonequilibrium opioid antagonist activity of 6,14-dideoxynaltrexone derivatives.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1987 Jun; 30(6):1040-4. PubMed ID: 3035177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS; Takemori AE
    Life Sci; 1985 Feb; 36(8):801-5. PubMed ID: 2983171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
    Porreca F; LoPresti D; Ward SJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N,N-dialkylated leucine enkephalins as potential delta opioid receptor antagonists.
    Lovett JA; Portoghese PS
    J Med Chem; 1987 Jul; 30(7):1144-9. PubMed ID: 3037078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of analogues of beta-chlornaltrexamine and beta-funaltrexamine at opioid receptors.
    Portoghese PS; Rein MD; Takemori AE
    J Med Chem; 1986 Oct; 29(10):1861-4. PubMed ID: 3020245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved assays for the assessment of kappa- and delta-properties of opioid ligands.
    Ward SJ; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1982 Nov; 85(2):163-70. PubMed ID: 6295778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine.
    Portoghese PS; Nagase H; Takemori AE
    J Med Chem; 1988 Jul; 31(7):1344-7. PubMed ID: 2838632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antagonists at the opiate delta-receptor.
    Shaw JS; Miller L; Turnbull MJ; Gormley JJ; Morley JS
    Life Sci; 1982 Sep 20-27; 31(12-13):1259-62. PubMed ID: 6128652
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible blockage of opioid receptor types by ester homologues of beta-funaltrexamine.
    Schoenecker JW; Takemori AE; Portoghese PS
    J Med Chem; 1986 Oct; 29(10):1868-71. PubMed ID: 3020246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
    Portoghese PS; Nagase H; Lipkowski AW; Larson DL; Takemori AE
    J Med Chem; 1988 Apr; 31(4):836-41. PubMed ID: 2832604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptors in the mouse ileum.
    Smith CF; Waldron C; Brook NA
    Arch Int Pharmacodyn Ther; 1988; 291():122-31. PubMed ID: 2835021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of melphalan-containing N,N-dialkylenkephalin analogues as irreversible antagonists of the delta opioid receptor.
    Lovett JA; Portoghese PS
    J Med Chem; 1987 Sep; 30(9):1668-74. PubMed ID: 3041000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS; Lipkowski AW; Takemori AE
    Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of N-methyl-alpha- and -beta-funaltrexamine at opioid receptors.
    Mohamed MS; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1986 Aug; 29(8):1551-3. PubMed ID: 3016272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens.
    Smith CB; Bennett-Kelly L; Woods JH
    Neuropeptides; 1984 Dec; 5(1-3):161-4. PubMed ID: 6099488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.
    Sayre LM; Larson DL; Takemori AE; Portoghese PS
    J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.